Tim Tyson
Director/Miembro de la Junta en SYROS PHARMACEUTICALS, INC. .
Fortuna: 148 871 $ al 31/01/2020
Relaciones activas
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Steve Hoffman | M | 61 |
Tyme, Inc.
Tyme, Inc. BiotechnologyHealth Technology Part of Syros Pharmaceuticals, Inc., Tyme, Inc. is a company that provides research and development services focused on developing drug candidates for the treatment of cancer. The company is based in Wilmington, DE. Steve Hoffman has been the CEO of the company since 2013. Tyme was acquired by Tyme Technologies, Inc., part of Syros Pharmaceuticals, Inc. from September 19, 2022 on March 05, 2015. | 13 años |
Nancy Simonian | M | 63 | 12 años | |
Michael Demurjian | M | 60 |
Tyme, Inc.
Tyme, Inc. BiotechnologyHealth Technology Part of Syros Pharmaceuticals, Inc., Tyme, Inc. is a company that provides research and development services focused on developing drug candidates for the treatment of cancer. The company is based in Wilmington, DE. Steve Hoffman has been the CEO of the company since 2013. Tyme was acquired by Tyme Technologies, Inc., part of Syros Pharmaceuticals, Inc. from September 19, 2022 on March 05, 2015. | 9 años |
Richard Cunningham | M | 54 |
Icagen-T, Inc.
Icagen-T, Inc. BiotechnologyHealth Technology Icagen-T, Inc. engages in development of pharmaceutical drugs. The company is headquartered in Oro Valley, AZ. | 3 años |
Donald DeGolyer | M | 63 |
Tyme, Inc.
Tyme, Inc. BiotechnologyHealth Technology Part of Syros Pharmaceuticals, Inc., Tyme, Inc. is a company that provides research and development services focused on developing drug candidates for the treatment of cancer. The company is based in Wilmington, DE. Steve Hoffman has been the CEO of the company since 2013. Tyme was acquired by Tyme Technologies, Inc., part of Syros Pharmaceuticals, Inc. from September 19, 2022 on March 05, 2015. | 6 años |
Gerald H. Sokol | M | 81 |
Tyme, Inc.
Tyme, Inc. BiotechnologyHealth Technology Part of Syros Pharmaceuticals, Inc., Tyme, Inc. is a company that provides research and development services focused on developing drug candidates for the treatment of cancer. The company is based in Wilmington, DE. Steve Hoffman has been the CEO of the company since 2013. Tyme was acquired by Tyme Technologies, Inc., part of Syros Pharmaceuticals, Inc. from September 19, 2022 on March 05, 2015. | 10 años |
Keith Lyon | M | - |
TriRx Pharmaceutical Services LLC
TriRx Pharmaceutical Services LLC Medical/Nursing ServicesHealth Services TriRx Pharmaceutical Services LLC operates contract development and manufacturing organization which serving the biopharmaceutical market. The company was founded by Keith Lyon and Timothy C. Tyson and is headquartered in Norwalk, CT. | - |
Conley Chee | M | 54 | 3 años | |
Richard Young | M | 70 | 13 años | |
Pat LePore | M | 69 |
Tyme, Inc.
Tyme, Inc. BiotechnologyHealth Technology Part of Syros Pharmaceuticals, Inc., Tyme, Inc. is a company that provides research and development services focused on developing drug candidates for the treatment of cancer. The company is based in Wilmington, DE. Steve Hoffman has been the CEO of the company since 2013. Tyme was acquired by Tyme Technologies, Inc., part of Syros Pharmaceuticals, Inc. from September 19, 2022 on March 05, 2015. | 9 años |
Peter Wirth | M | 73 | 7 años | |
Andrew Oh | M | 53 | 2 años | |
S. Gail Eckhardt | M | 66 | 4 años | |
Mark Korb | M | 57 |
Icagen-T, Inc.
Icagen-T, Inc. BiotechnologyHealth Technology Icagen-T, Inc. engages in development of pharmaceutical drugs. The company is headquartered in Oro Valley, AZ.
Icagen, Inc.
Icagen, Inc. Medical SpecialtiesHealth Technology Icagen, Inc. engages in the development of pharmaceutical and drug discovery instruments. It offers chemistry, biology, and ion channels and transporters. The company was founded by Benjamin P. Warner and Frank Jeremiel Zimmerman in 1992 and is headquartered in Durham, NC. | - |
Jim Scandura | M | - |
TriRx Pharmaceutical Services LLC
TriRx Pharmaceutical Services LLC Medical/Nursing ServicesHealth Services TriRx Pharmaceutical Services LLC operates contract development and manufacturing organization which serving the biopharmaceutical market. The company was founded by Keith Lyon and Timothy C. Tyson and is headquartered in Norwalk, CT. | - |
Deborah Dunsire | M | 61 | 3 años | |
Karen Hunady | F | - | 2 años | |
James Ford | M | - | 29 años | |
Marsha Fanucci | F | 70 | 9 años | |
Srini Akkaraju Akkaraju | M | 56 | 7 años | |
Jason Haas | M | 56 | 3 años | |
Lisa Roberts | F | - | 12 años | |
Graham Rivers | M | - | 26 años | |
Kristin Stephens | F | 51 | - | |
Michael Taglich | M | 57 |
Icagen, Inc.
Icagen, Inc. Medical SpecialtiesHealth Technology Icagen, Inc. engages in the development of pharmaceutical and drug discovery instruments. It offers chemistry, biology, and ion channels and transporters. The company was founded by Benjamin P. Warner and Frank Jeremiel Zimmerman in 1992 and is headquartered in Durham, NC. | - |
Lori Peterson | F | - |
Icagen, Inc.
Icagen, Inc. Medical SpecialtiesHealth Technology Icagen, Inc. engages in the development of pharmaceutical and drug discovery instruments. It offers chemistry, biology, and ion channels and transporters. The company was founded by Benjamin P. Warner and Frank Jeremiel Zimmerman in 1992 and is headquartered in Durham, NC. | - |
David Roth | M | 61 | 9 años | |
Nathan H. Zahler | M | - |
Icagen, Inc.
Icagen, Inc. Medical SpecialtiesHealth Technology Icagen, Inc. engages in the development of pharmaceutical and drug discovery instruments. It offers chemistry, biology, and ion channels and transporters. The company was founded by Benjamin P. Warner and Frank Jeremiel Zimmerman in 1992 and is headquartered in Durham, NC. | 11 años |
Clive P. Kabatznik | M | 66 |
Icagen, Inc.
Icagen, Inc. Medical SpecialtiesHealth Technology Icagen, Inc. engages in the development of pharmaceutical and drug discovery instruments. It offers chemistry, biology, and ion channels and transporters. The company was founded by Benjamin P. Warner and Frank Jeremiel Zimmerman in 1992 and is headquartered in Durham, NC. | - |
David Redfern | M | 57 | 30 años | |
Gerald Quirk | M | 56 | - | |
Douglas S. Krafte | M | 64 |
Icagen-T, Inc.
Icagen-T, Inc. BiotechnologyHealth Technology Icagen-T, Inc. engages in development of pharmaceutical drugs. The company is headquartered in Oro Valley, AZ. | - |
John M. Rothman | M | 75 | 4 años | |
Douglas Giordano | M | 61 |
Icagen, Inc.
Icagen, Inc. Medical SpecialtiesHealth Technology Icagen, Inc. engages in the development of pharmaceutical and drug discovery instruments. It offers chemistry, biology, and ion channels and transporters. The company was founded by Benjamin P. Warner and Frank Jeremiel Zimmerman in 1992 and is headquartered in Durham, NC. | 13 años |
Edward Roffman | M | 74 |
Icagen, Inc.
Icagen, Inc. Medical SpecialtiesHealth Technology Icagen, Inc. engages in the development of pharmaceutical and drug discovery instruments. It offers chemistry, biology, and ion channels and transporters. The company was founded by Benjamin P. Warner and Frank Jeremiel Zimmerman in 1992 and is headquartered in Durham, NC. | 13 años |
Shetaun Deering | F | - |
Icagen, Inc.
Icagen, Inc. Medical SpecialtiesHealth Technology Icagen, Inc. engages in the development of pharmaceutical and drug discovery instruments. It offers chemistry, biology, and ion channels and transporters. The company was founded by Benjamin P. Warner and Frank Jeremiel Zimmerman in 1992 and is headquartered in Durham, NC. | 4 años |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Peter R. Dolan | M | 68 | 18 años | |
J. Pearson | M | 64 |
Bausch Health Americas, Inc.
Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ. | 2 años |
Richard Sykes | M | 79 |
Glaxo Wellcome Plc
| 7 años |
Tommy Thompson | M | 81 |
Tyme, Inc.
Tyme, Inc. BiotechnologyHealth Technology Part of Syros Pharmaceuticals, Inc., Tyme, Inc. is a company that provides research and development services focused on developing drug candidates for the treatment of cancer. The company is based in Wilmington, DE. Steve Hoffman has been the CEO of the company since 2013. Tyme was acquired by Tyme Technologies, Inc., part of Syros Pharmaceuticals, Inc. from September 19, 2022 on March 05, 2015. | 5 años |
Charles A. Heimbold | M | - | 20 años | |
John E. Celentano | M | 64 | 31 años | |
Ben Taylor | M | 46 | 3 años | |
Albert Medwar | M | - | 11 años | |
Julian Heslop | M | 70 |
Glaxo Wellcome Plc
| 13 años |
James Biehl | M | 60 | 5 años | |
Charles Bramlage | M | 63 |
Bausch Health Americas, Inc.
Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ. | 9 años |
Douglas Michels | M | 66 | 4 años | |
William Louv | M | - | 21 años | |
Kevin Kotler | M | 53 | 4 años | |
Paul Sturman | M | 63 | - | |
Geoffrey Glass | M | 50 |
Bausch Health Americas, Inc.
Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ. | 4 años |
William B. Stone | M | 81 | 16 años | |
Mark W. Durand | M | 64 | 17 años | |
Peter Greenleaf | M | 54 | 4 años | |
Charles Bancroft | M | 65 | 36 años | |
Rosemary Crane | F | 64 | 20 años | |
David P. Carberry | M | 71 | 5 años | |
Jonathan Eckard | M | 50 | 5 años | |
Robert Dickey | M | 68 |
Tyme, Inc.
Tyme, Inc. BiotechnologyHealth Technology Part of Syros Pharmaceuticals, Inc., Tyme, Inc. is a company that provides research and development services focused on developing drug candidates for the treatment of cancer. The company is based in Wilmington, DE. Steve Hoffman has been the CEO of the company since 2013. Tyme was acquired by Tyme Technologies, Inc., part of Syros Pharmaceuticals, Inc. from September 19, 2022 on March 05, 2015. | 2 años |
Niraj Vasisht | M | 61 | 13 años | |
Mary Coleman | F | - | - | |
William Mark Watson | M | 73 | 5 años | |
Akber Pabani | M | 58 | - | |
Alex Howarth | M | 55 | 10 años | |
Todd Davis | M | 63 | 4 años | |
Harrison Bains | M | 80 | 16 años | |
Samuel Sears | M | 80 | 7 años | |
Lawrence Hamilton | M | 66 | 8 años | |
Béatrice J. Cazala | F | 67 | 32 años | |
Robert Rosewell Chai-Onn | M | 52 |
Bausch Health Americas, Inc.
Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ. | 6 años |
Mark Alles | M | 64 | 4 años | |
Michele Korfin | F | 53 | 2 años | |
Herm Cukier | M | 57 | 2 años | |
Phillip Sharp | M | 79 | 10 años | |
James D. Darnley | M | - | 1 años | |
Thomas D'Alonzo | M | 80 | 5 años | |
Michèle Barzach | M | - | 7 años | |
Barry I. Feinberg | M | 68 | 4 años | |
Michael H. Baker | M | - |
Jacksonville State University
| 6 años |
Michael A. Griffith | M | 66 |
Aptuit LLC
Aptuit LLC Miscellaneous Commercial ServicesCommercial Services Aptuit LLC engages in the development of pharmaceutical and biotechnological products. Its offerings include drug design and discovery, preclinical biosciences, API development and manufacture, solid state chemistry, solid and oral dosage form development and manufacture, integrated drug discovery and drug development, Aptuit INDiGO, and physical and analytical chemistry services. The company was founded in December 2004 and is headquartered in Greenwich, CT. | 4 años |
Amir Nashat | M | 51 | 8 años | |
Robert J. DiVasto | M | 68 |
Bausch Health Americas, Inc.
Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ.
Glaxo Wellcome Plc
| 15 años |
Bruce Frasier | M | - |
US Military Academy
| 4 años |
Jill DeSimone | F | 68 | 32 años | |
David N. Ruckert | M | 86 | 16 años | |
George Zavoico | M | - | - | |
Claude Nicaise | M | 71 | 25 años | |
Raymond T. Keane | M | 65 | 20 años | |
Charles M. Urbain | M | 70 | 14 años | |
Roger L. Bruley | M | - |
US Military Academy
| 4 años |
Michael S. Eison | M | - | - | |
H. Eric C. Peitz | M | - |
US Military Academy
| 4 años |
Jonathan Faith | M | - |
US Military Academy
| 4 años |
Henry Y. Pan | M | 77 | 7 años | |
Herman Bulls | M | 68 |
US Military Academy
| 4 años |
Frederick B. Oleson | M | - | 9 años | |
Donald Hayden | M | 68 | 25 años | |
Samuel Moed | M | 62 | 32 años | |
Robert E. Allen | M | - | 21 años |
Estadísticas
País | Relaciones | % del total |
---|---|---|
Estados Unidos | 92 | 92.00% |
Reino Unido | 9 | 9.00% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Tim Tyson
- Red Personal